Guaifenesin 600 Mg Tablet, Extended Release
Product Images NDC 67296-2351

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Guaifenesin 600 Mg (NDC 67296-2351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Mckesson Ft Guaifenesin 600mg 40ct Carton)

Packaging label for Foster Thrive Mucus Relief Guaifenesin 600 mg Extended-Release Tablets, an expectorant with 12-hour relief. The label shows 40 extended-release tablets and includes warnings, directions, inactive ingredients, and tamper-evident information. Manufactured by McKesson Corporation and distributed by McKesson Corp.*

FDA Label Image

Carton (Mckesson Ft Guaifenesin 1200mg 14ct Carton)

Packaging label for Foster & Thrive Maximum Strength Mucus Relief, containing Guaifenesin 1200 mg extended-release tablets. The label states expectorant use, 14 tablets per package, and 12-hour relief. It includes a tablet image showing 3-layer design and dosing instructions. The labeler is McKesson Corp, with a note that the product is made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.